Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "sandoz inc"

Apricus Biosciences Enters Into Common Stock Purchase Agreement With Aspire Capital
PharmaVOICE

BRIEF-Apricus Biosciences expands existing partnership with Fe...

July 25 Apricus Biosciences * Apricus biosciences inc says apricus and sandoz agree to mutually terminate license agreement * Apricus eligible to receive additional $3.6 million in upfront and pre-commercialization milestone payments for ... Reuters UK, 1 month ago
Selecta Biosciences Provides Corporate Update Citybizlist, 2 weeks ago
[x]  

3 images for "sandoz inc"

Money Control, 6 months ago
India Infoline, 6 months ago
Business Standard, 6 months ago

AstraZeneca Resolves Faslodex Patent Litigation in US

By Razak Musah Baba LONDON--AstraZeneca PLC (AZN.LN) has entered an agreement with Sandoz, Inc. and affiliates to resolve a U.S. patent litigation relating to its hormonal therapy drug Faslodex, the British pharmaceutical giant said Wednesday. ...
 Morningstar.com1 month ago AstraZeneca Enters Into Deal To Resolve Faslodex Patent Litigation In US  Pharmacy Choice1 month ago ASTRAZENECA : Resolves Faslodex Patent Litigation in US  4 Traders1 month ago ASTRAZENECA : AZ resolves Faslodex patent litigation in the US  4 Traders1 month ago
[x]  

Pfizer Inc. v. Sandoz Inc

Case Name: ., C.A. No. 13-1110-GMS, 2016 U.S. Dist. LEXIS 52762 (D. Del. Apr. 20, 2016) (Sleet, J.) Drug Product and Patent(s)-in-Suit: ToviazĀ® (fesoterodine fumarate); U.S. Patents Nos. 7,384,980 (the 980 patent), 7,855,230 (the 230 patent), ...
 JD Supra2 weeks ago Spectrum Pharms., Inc. v. Burwell  JD Supra1 month ago

Federal Circuit Confirms That the BPCIA Always Requires Post-Licensure Notice

The Federal Circuit answered one of the questions left open by its July 27, 2015, decision in Amgen Inc. v. Sandoz Inc. (Appeal No. 2015-1499): whether the 180-day commercial marketing notice under the Biologics Price Competition and Innovation Act ...
 JD Supra1 month ago No Exception to Statutory Requirement that a Biosimilar Applicant Provide Notice of Intent to Market its Product  JD Supra1 month ago Amgen Inc. v. Apotex Inc. (Fed. Cir. 2016)  JD Supra1 month ago New Guidance on Mandatory Notice in the Biosimilar Patent Dance  JD Supra1 month ago
[x]  
Bidness Etc

AbbVie Inc, Amgen, Inc: Lengthy Legal Battle Over Humira Begins

AbbVie Inc. ( NYSE:ABBV ) filed a lawsuit against rival Amgen on Friday, claiming the latter's proposed copy of its top-selling drug Humira infringed on at least 10 of the original's patents. The company warned that additional patent infringement ...
 Bidness Etc2 weeks ago AbbVie Inc: New Drugs May Overcome Humira Loss  Bidness Etc3 weeks ago Will Amgen, Inc. Surprise Investors this Quarter?  Bidness Etc1 month ago AbbVie Inc: FDA May Favor Early Entry for Humira Biosimilar  Bidness Etc1 month ago
[x]  

Fitch Rates Amgen Inc.'s Notes Offering 'BBB'

CHICAGO--( BUSINESS WIRE )--Fitch Ratings has assigned a 'BBB' rating to Amgen's senior unsecured notes offering. The ratings apply to $34.2 billion of debt outstanding at June 30, 2016. A full list of Amgen's ratings can be found at the end of ...
 Business Wire2 weeks ago Fitch Affirms Amgen Inc.'s IDR at 'BBB'; Outlook Stable  Business Wire3 weeks ago
[x]  

Edited Transcript of SELB earnings conference call or presentation 9-Aug-16 12:30pm GMT

Q2 2016 Selecta Biosciences Inc Earnings Call TEXT version of Transcript ================================================================================ Corporate Participants ...
 Yahoo! Finance2 weeks ago Pernix Therapeutics Holdings (PTX) Q2 2016 Results - Earnings Call Transcript  Seeking Alpha2 weeks ago Impax Laboratories (IPXL) George Frederick Wilkinson on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha2 weeks ago Apricus Biosciences' (APRI) CEO Richard Pascoe on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha3 weeks ago

Versartis' Long-Acting Somavartan Could Replace Current Treatments In Growth Hormone Deficiency

Jul.28.16 | About: Versartis, Inc. (VSAR) Follow Registered investment advisor, hedge fund manager, research analyst, biotech | Summary Versartis, Inc. (NASDAQ: VSAR) is developing a long-acting (once or twice monthly) formulation of ...
 Seeking Alpha1 month ago

Celgene : Dr. Jerome Zeldis, M.D., Ph.D., former Chief Medical Officer of Celgene, to Join Sorrento as Chief Medical Officer and President of Clinical Development

SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; "Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer, pain management, inflammation and autoimmune ...
 4 Traders1 week ago Dr. Jerome Zeldis, M.D., Ph.D., former Chief Medical Officer of Celgene, to Join Sorrento as Chief Medical Officer and President of Clinical Development  PR Newswire1 week ago Former Celgene Chief Exec Joins Sorrento as Chief Medical Officer and President of Clinical Development  BioSpace1 week ago
[x]  

Richard S. Levy, M. D., Appointed to Madrigal Board of Directors

FORT WASHINGTON, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- MADRIGAL PHARMACEUTICALS, Inc. ( MDGL ), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for cardiovascular, metabolic and ...
 CPhI.cn2 weeks ago MADRIGAL PHARMACEUTICALS : Richard S. Levy, M. D., Appointed to Madrigal Board of Directors  4 Traders2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less